A study out of the University of Chicago is getting us excited for all the best reasons.
An interdisciplinary team of researchers from the University of Chicago has found evidence that cannabidiol (CBD), a product of the cannabis plant, can inhibit infection by SARS-CoV-2 in human cells and in mice.https://www.uchicagomedicine.org/forefront/research-and-discoveries-articles/researchers-recommend-clinical-trials-for-cbd
Why is this so exciting?
Because the data is significant enough to recommend clinical trials to further investigate.
It’s no secret we’re fans of CBD around here. CBD has anti-anxiety, anti-inflammatory, anti-psychotic, anti-nausea, anti-oxidative, and anti-rheumatoid arthritic properties.
It’s the anti-inflammatory properties that really caught researchers’ attention.
“CBD has anti-inflammatory effects, so we thought that maybe it would stop the second phase of COVID infection involving the immune system, the so-called ‘cytokine storm.’ Surprisingly, it directly inhibited viral replication in lung cells,” said Marsha Rosner, PhD, Charles B. Huggins Professor in the Ben May Department of Cancer Research and a senior author of the study.https://www.uchicagomedicine.org/forefront/research-and-discoveries-articles/researchers-recommend-clinical-trials-for-cbd
The same article at U Chicago Medicine included this important piece of information:
CBD did not affect the ability of SARS-CoV-2 to enter the cell. Instead, CBD was effective at blocking replication early in the infection cycle and six hours after the virus had already infected the cell.https://www.uchicagomedicine.org/forefront/research-and-discoveries-articles/researchers-recommend-clinical-trials-for-cbd
Real world data matched the hope of the lab data.
And the success of CBD wasn’t limited to the laboratory: An analysis of 1,212 patients from the National COVID Cohort Collaborative revealed that patients taking a medically prescribed oral solution of CBD for the treatment of epilepsy tested positive for COVID-19 at significantly lower rates than a sample of matched patients from similar demographic backgrounds who were not taking CBD.https://www.uchicagomedicine.org/forefront/research-and-discoveries-articles/researchers-recommend-clinical-trials-for-cbd
What kind of CBD might work?
The researchers were quick to point out that “special brownies” won’t do the trick. A high quality, high potency cannabidiol is necessary.
Fortunately, we’ve got great recommendations for you.
Instead, choose a high-quality tincture that includes CBG. The best way to take CBD to help with COVID is as a tincture under your tongue. It’s the most direct way to your bloodstream!
If you don’t want to wait for clinical trials to try CBD or CBG for COVID, here’s what we suggest:
As always, check with your doctor before trying CBD. And if you’re new to CBD, make sure you’re aware of the grapefruit effect before trying it.